WebJan 13, 2013 · A 51-year-old woman developed crystalline maculopathy during treatment with tamoxifen for breast cancer. The woman, who had hypertension and type 2 … WebJun 22, 2024 · Drug-induced crystalline maculopathy has been reported secondary to tamoxifen use for breast cancer treatment. It could be misdiagnosed as macular …
Retinal Physician - Retinal and Uveal Drug Toxicity
WebFA should be obtained in the clinical setting of tamoxifen induced crystalline retinopathy. If there are numerous crystals or macular edema is present the medication should have a dose adjustment or altogether discontinuation. In very early stages retinal crystals are … Ophthalmologists, medical students and eye care professionals are eligible for … Pages in category "Retina/Vitreous" The following 200 pages are in this category, … Getting Started on the EyeWiki provides information on how to update content on … This category contains all article categories. It has default form This category uses … some of the properties of plasma
Tamoxifen-associated eye disease. A review - PubMed
WebNov 1, 2006 · Crystalline retinopathy is an intriguing group of disorders characterized by refractile lesions or deposits of the macula with a diverse array of etiologies including toxic, metabolic, genetic, degenerative, and idiopathic causes. ... canthaxanthine crystals, nitrofurantoin retinopathy, nitrofurantoin crystals, tamoxifen retinopathy, tamoxifen ... WebJul 1, 2010 · Tamoxifen is an antiestrogen commonly used in low doses (20 mg daily) as a complementary therapy in the treatment of breast cancer [1] it has been suggested that tamoxifen induces RPE cell loss... WebInner retinal hyperreflective deposits were identified by OCT in all the patients. Conclusions: High-dose tamoxifen therapy may result in peripheral crystalline retinopathy in addition to perifoveal opacities. Angiographic evidence of macular edema may not unanimously correlate with presence of CME on OCT in these cases. Publication types some of these days karaoke